Armistice Capital »

Philip Morris International shares owned by Armistice Capital

Quarter-by-quarter ownership of Philip Morris International (PM) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Philip Morris International

Tip: Access up to 7 years of quarterly data

All positions including Philip Morris International held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Philip Morris International by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $11M 121k 92.58
2023-06-30 $22M 224k 97.62

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Philip Morris International

Vanguard Group
BlackRock
Geode Capital Management
Morgan Stanley
Jpmorgan Chase & Co
Wellington Management Company
T. Rowe Price Associates
Bank of America Corporation
FMR
Charles Schwab Investment Management
Viking Global Investors
Northern Trust
Nuveen Asset Management
Franklin Resources
Bank of New York Mellon

View all funds holding Philip Morris International